Proffitt & Goodson Inc Novo Nordisk A S Transaction History
Proffitt & Goodson Inc
- $600 Million
- Q4 2024
A detailed history of Proffitt & Goodson Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Proffitt & Goodson Inc holds 2,244 shares of NVO stock, worth $130,892. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,244
Previous 2,205
1.77%
Holding current value
$130,892
Previous $262,000
26.34%
% of portfolio
0.03%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding NVO
# of Institutions
1,867Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.16 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$904 Million0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$758 Million1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$737 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$712 Million0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $132B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...